BioReference Laboratories dedication to Science, Quality and Service make it the Preferred Clinical Laboratory of Embry Women’s Health.
BioReference Laboratories is the third largest full service clinical diagnostic laboratory in the U.S. providing testing and related services to physician offices, clinics, hospitals, long term care facilities, employers, governmental units and correctional institutions. We offer a comprehensive test list focusing on molecular diagnostics, anatomical pathology, genetics, and women’s health. Moreover, through its GeneDx subsidiary, BioReference has an international presence in more than 50 countries around the world.
Our client retention is unparalleled in the industry because we are much more than just the provider of quality diagnostics. We have grown primarily as a result of our differentiating business model which is both physician-centric – providing superior service and support – and clinically relevant – providing innovative and disruptive technology to improve patient outcomes. What makes us different from other labs is the added value we bring through personal attention and professional support and the effort we make to understand our clients’ needs. Our success comes from helping clinicians deliver premium services to the patients in their care – through a full menu of cost–conscious testing options and cutting edge technologies with clinically–relevant results, all in a medically and fiscally responsible manner.
They are contracted with virtually all national health plans (UHC, Cigna, Aetna, Humana, Coventry and most Blues Plans)
Their medical staff is comprised of more than 160 MD, PhD, or other Professional level clinicians and scientists with expertise across all fields including Pathology, Cytogenetics, Coagulation, Genetics, and R&D.;
BioReference employs more than 5000 people working together to support the needs of our clients and their patients.
BioReference is fully licensed and accredited by The College of American Pathologists (CAP).
All laboratory test results are published electronically. They are sent to the Embry Women’s Health Patient Portal upon review by your provider.